The George Institute For Global Health
United Kingdom


Praveen D, Peiris DP, MacMahon S, et al. Cardiovascular disease risk and comparison of different strategies for blood pressure management in rural India 11 Medical and Health Sciences 1102 Cardiorespiratory Medicine and Haematology 11 Medica. BMC Public Health. 2018;18. doi:10.1186/s12889-018-6142-x.
Praveen D, Peiris DP, MacMahon S, et al. Cardiovascular disease risk and comparison of different strategies for blood pressure management in rural India. BMC Public Health. 2018;18:1264. doi:10.1186/s12889-018-6142-x.
Rahimi K, Mohseni H, Kiran A, et al. Elevated blood pressure and risk of aortic valve disease: A cohort analysis of 5.4 million UK adults. European Heart Journal. 2018;39:3596 - 3603. doi:10.1093/eurheartj/ehy486.
Rahimi K, Mohseni H, Otto CM, et al. Elevated blood pressure and risk of mitral regurgitation: A longitudinal cohort study of 5.5 million United Kingdom adults. PLoS Med. 2017;14(10):e1002404. doi:10.1371/journal.pmed.1002404.
Brugts JJ, Bertrand M, Remme W, et al. The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials. Cardiovasc Drugs Ther. 2017;31(4):391-400. doi:10.1007/s10557-017-6747-9.
Hyun KK, Redfern J, Patel A, et al. Gender inequalities in cardiovascular risk factor assessment and management in primary healthcare. Heart. 2017;103(7):492-498. doi:10.1136/heartjnl-2016-310216.
MacMahon S. From Telemedicine to Wearables: The Impact of Technological Innovations on Global Health. Topic: Systematic Medical Appraisal, Referral and Treatment for NCDs. In: Winter Meeting Clinton Global Initiative. Winter Meeting Clinton Global Initiative. New York, USA; 2016.
Collins R, Reith C, Emberson J, et al. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet. 2016;388(10059):2532-2561. doi:10.1016/S0140-6736(16)31357-5.
Li N, Yan LL, Niu W, et al. The Effects of a Community-Based Sodium Reduction Program in Rural China - A Cluster-Randomized Trial. PLoS One. 2016;11:e0166620.
Emdin CA, Anderson SG, Salimi-Khorshidi G, et al. Usual blood pressure, atrial fibrillation and vascular risk: evidence from 4.3 million adults. International Journal of Epidemiology. 2016.
Wu Y, Benjamin EJ, MacMahon S. Prevention and Control of Cardiovascular Disease in the Rapidly Changing Economy of China. Circulation. 2016;133:2545-60.
Wong MG, Perkovic V, Chalmers J, et al. Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON. Diabetes Care. 2016;pii: dc152322. .
Praveen D, Patel A, Raghu A, et al. SMARTHealth India: Development and Field Evaluation of a Mobile Clinical Decision Support System for Cardiovascular Diseases in Rural India. JMIR Mhealth Uhealth. 2014;2:e54.
Sundstrom J, Arima H, Woodward M, et al. Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data. Lancet. 2014;384:591-8.
Rahimi K, Bennett D, Conrad N, et al. Risk prediction in patients with heart failure: a systematic review and analysis. JACC Heart Failure. 2014;2:440-6.
Brugts JJ, Arima H, Remme W, et al. The incidence and clinical predictors of ACE-inhibitor induced dry cough by perindopril in 27,492 patients with vascular disease. International Journal of Cardiology. 2014;176(3):718-23.
Arima H, Anderson CS, Omae T, et al. Degree of blood pressure reduction and recurrent stroke: the PROGRESS trial. Journal of Neurology, Neurosurgery, and Psychiatry. 2014;pii: jnnp-2014-307856.
Yan LL, Fang W, Delong E, et al. Population impact of a high cardiovascular risk management program delivered by village doctors in rural China: design and rationale of a large, cluster-randomized controlled trial. BMC Public Health. 2014;14:345.